应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01558 东阳光长江药业
停牌 12-05 16:00:00
15.880
+0.000
0.00%
最高
15.880
最低
15.880
成交量
0.00
今开
15.880
昨收
15.880
日振幅
0.00%
总市值
139.74亿
流通市值
103.82亿
总股本
8.80亿
成交额
0.00
换手率
0.00%
流通股本
6.54亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
年内险资29次举牌上市公司 时隔六年再现险资增持险企
21世纪经济报道 · 08-14
年内险资29次举牌上市公司 时隔六年再现险资增持险企
东阳光长江药业(01558)上市地位自8月5日下午4时正起撤销
智通财经 · 08-05
东阳光长江药业(01558)上市地位自8月5日下午4时正起撤销
东阳光药(06887.HK)整体上市,研产销一体化重塑医药龙头价值,市值有望快速突破500亿
智通财经 · 08-04
东阳光药(06887.HK)整体上市,研产销一体化重塑医药龙头价值,市值有望快速突破500亿
东阳光药三靶点 1 类新药启动临床
Insight数据库 · 08-04
东阳光药三靶点 1 类新药启动临床
东阳光长江药业(01558)将于10月31日派发特别股息每股1.5港元
智通财经 · 07-31
东阳光长江药业(01558)将于10月31日派发特别股息每股1.5港元
【重磅】东阳光药1类新药来袭,掘金2300亿市场
米内网 · 07-30
【重磅】东阳光药1类新药来袭,掘金2300亿市场
深交所:将东阳光长江药业调出港股通标的证券名单
界面 · 07-30
深交所:将东阳光长江药业调出港股通标的证券名单
每日卖空追踪 | 东阳光长江药业 07月29日卖空量成交80.16万股,卖空比例为4.15%
市场透视 · 07-29
每日卖空追踪 | 东阳光长江药业 07月29日卖空量成交80.16万股,卖空比例为4.15%
东阳光长江药业07月28日遭主力抛售331.8万元
市场透视 · 07-28
东阳光长江药业07月28日遭主力抛售331.8万元
东阳光长江药业(01558)与东阳光药的合并协议获股东大会通过 预计东阳光药将于8月7日上市
智通财经网 · 07-21
东阳光长江药业(01558)与东阳光药的合并协议获股东大会通过 预计东阳光药将于8月7日上市
每日卖空追踪 | 东阳光长江药业 07月16日卖空量成交12.16万股,卖空比例为1.25%
市场透视 · 07-16
每日卖空追踪 | 东阳光长江药业 07月16日卖空量成交12.16万股,卖空比例为1.25%
港股创新药概念股午后持续走高!丽珠医药涨超13%,复星医药涨超8%
老虎资讯综合 · 07-16
港股创新药概念股午后持续走高!丽珠医药涨超13%,复星医药涨超8%
东阳光长江药业盘中异动 股价大涨5.09%
市场透视 · 07-16
东阳光长江药业盘中异动 股价大涨5.09%
超越输血与EPO:东阳光药HEC53856将重塑化疗性贫血治疗格局
药时代 · 07-15
超越输血与EPO:东阳光药HEC53856将重塑化疗性贫血治疗格局
押注液冷与机器人,东阳光能靠新业务填补176亿财富窟窿吗?
新浪财经 · 07-14
押注液冷与机器人,东阳光能靠新业务填补176亿财富窟窿吗?
每日卖空追踪 | 东阳光长江药业 07月14日卖空量成交23.2万股,卖空比例为1.25%
市场透视 · 07-14
每日卖空追踪 | 东阳光长江药业 07月14日卖空量成交23.2万股,卖空比例为1.25%
港股创新药概念股再度走高!商保创新药目录有望落地
老虎资讯综合 · 07-14
港股创新药概念股再度走高!商保创新药目录有望落地
向全球输出创新,东阳光药有望成为中国创新药新样本
中国网财经 · 07-11
向全球输出创新,东阳光药有望成为中国创新药新样本
每日卖空追踪 | 东阳光长江药业 07月11日卖空量成交6.1万股,卖空比例为0.99%
市场透视 · 07-11
每日卖空追踪 | 东阳光长江药业 07月11日卖空量成交6.1万股,卖空比例为0.99%
每日卖空追踪 | 东阳光长江药业 07月10日卖空量成交11.1万股,卖空比例为1.61%
市场透视 · 07-10
每日卖空追踪 | 东阳光长江药业 07月10日卖空量成交11.1万股,卖空比例为1.61%
公司概况
公司名称:
东阳光长江药业
所属市场:
SEHK
上市日期:
--
主营业务:
宜昌东阳光长江药业股份有限公司是一家主要从事抗感染、内分泌及代谢类疾病等治疗领域产品开发、生产及销售的中国公司。该公司的主要产品包括可威(磷酸奥司他韦胶囊及颗粒)、尔同舒(苯溴马隆片)、欧美宁(替米沙坦片)、琳罗星(盐酸莫西沙星片),以及奥美沙坦酯片等产品。该公司还从事集采业务。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01558","market":"HK","secType":"STK","nameCN":"东阳光长江药业","latestPrice":15.88,"timestamp":1764921600000,"preClose":15.88,"halted":3,"volume":0,"delay":0,"floatShares":653767700,"shares":879967700,"eps":0.604161923380536,"marketStatus":"停牌","change":0,"latestTime":"12-05 16:00:00","open":15.88,"high":15.88,"low":15.88,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.604161923380536,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765157400000},"marketStatusCode":7,"adr":0,"listingDate":1451318400000,"exchange":"SEHK","adjPreClose":15.88,"dividendRate":0.094458,"openAndCloseTimeList":[[1764898200000,1764907200000],[1764910800000,1764921600000]],"volumeRatio":0,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01558/wiki","defaultTab":"wiki","newsList":[{"id":"2559950479","title":"年内险资29次举牌上市公司 时隔六年再现险资增持险企","url":"https://stock-news.laohu8.com/highlight/detail?id=2559950479","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559950479?lang=zh_cn&edition=full","pubTime":"2025-08-14 20:47","pubTimestamp":1755175620,"startTime":"0","endTime":"0","summary":"今年以来,险资举牌狂飙。 21世纪经济报道注意到,8月份未过半,险资举牌次数就达到6次,将年内举牌次数推升至29次,不仅大幅超2024年的20次,也超过2020年的26次,仅次于2015年的62次,至少锁定历史第二高。 记者梳理,险资29次举牌涉及22家上市公司,其中5家A股和17家H股。中国太保港股股价目前接近历史新高,时隔6年后再现险资首度举牌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/money/insurance/xzdt/2025-08-14/doc-infkyert6843981.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/insurance/xzdt/2025-08-14/doc-infkyert6843981.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0878004406.USD","PAImain","LU1981816686.USD","LU2476274308.USD","LU0561508036.HKD","MCHmain","02318","BK1550","LU1048588211.SGD","LU0052750758.USD","IE00BGHQDM52.EUR","LU0164880469.USD","IE0003895053.USD","MHImain","01558","LU0370786039.SGD","LU0244354667.USD","LU0384037296.USD","LU0762542818.HKD","LU1048596156.SGD","02833","LU1046422090.SGD","601318","LU1051768304.USD","LU0048580855.USD","LU2293587155.HKD","03145","IE00BVYPNQ40.USD","LU0417516902.SGD","LU1515016050.SGD","SG9999014674.SGD","LU1282649067.USD","HSI","82318","BK1184","PNGAY","HPAD.SI","LU0831093199.SGD","LU0823426480.USD","LU0359201885.HKD","LU0417516738.SGD","LU0328353924.USD","513600","LU0605514214.HKD","LU0051755006.USD","LU1044876610.USD","LU0348735423.USD","LU1481107354.HKD","LU1044874839.SGD","HHImain"],"gpt_icon":1},{"id":"2557133729","title":"东阳光长江药业(01558)上市地位自8月5日下午4时正起撤销","url":"https://stock-news.laohu8.com/highlight/detail?id=2557133729","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557133729?lang=zh_cn&edition=full","pubTime":"2025-08-05 06:38","pubTimestamp":1754347119,"startTime":"0","endTime":"0","summary":"智通财经APP讯,东阳光长江药业(01558)及要约人广东东阳光药业股份有限公司联合公布,联交所已经批准撤销H股在联交所的上市地位,于2025年8月5日下午4时正起生效。换股比率为1股H股可换取0.263614股要约人H股,即要约人将发行0.263614股要约人H股以换取1股H股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1325629.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"东阳光长江药业(01558)上市地位自8月5日下午4时正起撤销","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01558","BK1515"],"gpt_icon":0},{"id":"2556832743","title":"东阳光药(06887.HK)整体上市,研产销一体化重塑医药龙头价值,市值有望快速突破500亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2556832743","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556832743?lang=zh_cn&edition=full","pubTime":"2025-08-04 18:59","pubTimestamp":1754305140,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["07226","HSTECH","BK1191","01558","06887","BK1515","BK1574","BK4614","09939","BK1161","159938","06978","YANG","159992","HSCEI"],"gpt_icon":0},{"id":"2556802065","title":"东阳光药三靶点 1 类新药启动临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2556802065","media":"Insight数据库","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556802065?lang=zh_cn&edition=full","pubTime":"2025-08-04 16:58","pubTimestamp":1754297911,"startTime":"0","endTime":"0","summary":"8 月 4 日,药物临床试验登记与信息公示平台官网显示,东阳光药登记了一项HEC-007 注射液的 I 期临床试验。公开资料显示,这是该药首次启动临床。4 月 24 日,该药获得 CDE 批准,拟开展2 型糖尿病以及超重或肥胖两项适应症的临床试验。Insight 数据库显示,目前全球范围内尚无 GLP-1/GCG/GIP 三靶点新药获批上市,进度最快的是礼来瑞他鲁肽,已进入 III 期临床阶段。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804173454a474277f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804173454a474277f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01558","BK1191","BK1515"],"gpt_icon":0},{"id":"2555988696","title":"东阳光长江药业(01558)将于10月31日派发特别股息每股1.5港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555988696","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555988696?lang=zh_cn&edition=full","pubTime":"2025-07-31 18:14","pubTimestamp":1753956842,"startTime":"0","endTime":"0","summary":"智通财经APP讯,东阳光长江药业(01558)发布公告,该公司将于2025年10月31日派发特别股息每股1.5港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1324253.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","01558","BK1191"],"gpt_icon":0},{"id":"2555367011","title":"【重磅】东阳光药1类新药来袭,掘金2300亿市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2555367011","media":"米内网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555367011?lang=zh_cn&edition=full","pubTime":"2025-07-30 16:03","pubTimestamp":1753862607,"startTime":"0","endTime":"0","summary":"精彩内容近日,东阳光药的HEC-301注射液获批临床,用于治疗超重或肥胖,该新药是公司第二款获批临床的生物药1类新药。图1:东阳光药最新获批临床的1类新药来源:CDE官网图2:生物药的销售情况来源:米内网格局数据库在中国三大终端六大市场,生物药近几年保持稳步增长态势,2020年突破2000亿元,2024年涨至2300亿元,2025年Q1再有5.45%的增长,市场空间巨大。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730162023a6c951a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730162023a6c951a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01558","BK1191","BK1515"],"gpt_icon":0},{"id":"2555609300","title":"深交所:将东阳光长江药业调出港股通标的证券名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2555609300","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555609300?lang=zh_cn&edition=full","pubTime":"2025-07-30 08:36","pubTimestamp":1753835775,"startTime":"0","endTime":"0","summary":"7月30日,深交所公告,港股通标的证券名单发生调整并自2025年07月30日起生效,调出东阳光长江药业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730083615972682a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730083615972682a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","HSCEI","01558","HSTECH","BK1515"],"gpt_icon":0},{"id":"2555531060","title":"每日卖空追踪 | 东阳光长江药业 07月29日卖空量成交80.16万股,卖空比例为4.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555531060","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555531060?lang=zh_cn&edition=full","pubTime":"2025-07-29 16:30","pubTimestamp":1753777821,"startTime":"0","endTime":"0","summary":"东阳光长江药业北京时间07月29日,跌0.5%,卖空量成交80.16万股%,较上一交易日增加152.39%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729171719a6c78f38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250729171719a6c78f38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","01558"],"gpt_icon":0},{"id":"2554724171","title":"东阳光长江药业07月28日遭主力抛售331.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554724171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554724171?lang=zh_cn&edition=full","pubTime":"2025-07-28 16:15","pubTimestamp":1753690546,"startTime":"0","endTime":"0","summary":"07月28日, 东阳光长江药业股价跌0.25%,报收15.96元,成交金额3.0亿元,换手率2.96%,振幅5.75%,量比2.07。东阳光长江药业今日主力资金净流出331.8万元,连续5日净流出,上一交易日主力净流出3083.8万元。该股近5个交易日下跌7.96%,主力资金累计净流出5158.5万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流入4190.1万元,其中净流入天数为7日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728165629a6c5a2f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728165629a6c5a2f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","01558"],"gpt_icon":0},{"id":"2553764484","title":"东阳光长江药业(01558)与东阳光药的合并协议获股东大会通过 预计东阳光药将于8月7日上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2553764484","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553764484?lang=zh_cn&edition=full","pubTime":"2025-07-21 19:11","pubTimestamp":1753096291,"startTime":"0","endTime":"0","summary":"东阳光长江药业(01558)及要约人广东东阳光药业股份有限公司联合公布,有关以吸收...","market":"fut","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_22.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_22.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1320162.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1191","01558","BK1515","06887"],"gpt_icon":0},{"id":"2552367122","title":"每日卖空追踪 | 东阳光长江药业 07月16日卖空量成交12.16万股,卖空比例为1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552367122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552367122?lang=zh_cn&edition=full","pubTime":"2025-07-16 16:30","pubTimestamp":1752654625,"startTime":"0","endTime":"0","summary":"东阳光长江药业北京时间07月16日,涨3.64%,卖空量成交12.16万股%,较上一交易日减少47.4%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716172410a6ad1ff8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716172410a6ad1ff8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01558","BK1191","BK1515"],"gpt_icon":0},{"id":"1110572086","title":"港股创新药概念股午后持续走高!丽珠医药涨超13%,复星医药涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1110572086","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110572086?lang=zh_cn&edition=full","pubTime":"2025-07-16 13:39","pubTimestamp":1752644353,"startTime":"0","endTime":"0","summary":"7月16日,港股创新药概念股午后持续走高,$丽珠医药(01513)$涨超13%,$复星医药(02196)$涨超8%,$绿叶制药(02186)$涨超7%,$康方生物(09926)$涨近6%,$东阳光长江药业(01558)$、$亚盛医药-B(06855)$涨超4%。","market":"hk","thumbnail":"https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/c1cb237e736a4e03c939622e7b71e8e7"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4e7834c15c47c74e9bfd4d734ca81974","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02186","01558","01513","09926","HSCEI","BK4614","YANG","IE00B5MMRT66.SGD","IE00B543WZ88.USD","BK4139","BK1574","06978","LU0417516571.SGD","BK1515","AAPG","BK1606","02196","HSTECH","07226","LU1720050803.USD"],"gpt_icon":0},{"id":"2551115720","title":"东阳光长江药业盘中异动 股价大涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551115720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551115720?lang=zh_cn&edition=full","pubTime":"2025-07-16 09:55","pubTimestamp":1752630943,"startTime":"0","endTime":"0","summary":"2025年07月16日早盘09时55分,东阳光长江药业股票出现异动,股价快速拉升5.09%。截至发稿,该股报17.340港元/股,成交量201.82万股,换手率0.31%,振幅4.85%。资金方面,该股资金流入2342.55万港元,流出837.608万港元。东阳光长江药业股票所在的药品行业中,整体涨幅为0.39%。东阳光长江药业公司简介:宜昌东阳光长江药业股份有限公司是一家主要从事药品生产及销售业务的中国公司。该公司产品包括抗病毒药物、内分泌及代谢药物及心血管药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716095543a6ac421b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716095543a6ac421b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01558","BK1191","BK1515"],"gpt_icon":0},{"id":"2551275153","title":"超越输血与EPO:东阳光药HEC53856将重塑化疗性贫血治疗格局","url":"https://stock-news.laohu8.com/highlight/detail?id=2551275153","media":"药时代","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551275153?lang=zh_cn&edition=full","pubTime":"2025-07-15 12:41","pubTimestamp":1752554491,"startTime":"0","endTime":"0","summary":"据最新行业动态显示,东阳光药自主研发的低氧诱导因子脯氨酰羟化酶抑制剂靶向新药HEC53856片,已在国内正式启动针对非髓系恶性肿瘤化疗相关性贫血的II期临床试验。值得关注的是,HEC53856片是国内第二家进入肿瘤化疗性贫血适应症临床阶段的HIF-PHI项目,且肾性贫血适应症临床试验同步推进,研发进度处于行业前列。而HEC53856片凭借“一药双适应症”的战略布局,市场前景更为广阔,业内预测其在中国市场的年销售额将超50亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715124559a44b6938&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715124559a44b6938&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","01558","BK1191"],"gpt_icon":0},{"id":"2551900429","title":"押注液冷与机器人,东阳光能靠新业务填补176亿财富窟窿吗?","url":"https://stock-news.laohu8.com/highlight/detail?id=2551900429","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551900429?lang=zh_cn&edition=full","pubTime":"2025-07-14 17:01","pubTimestamp":1752483670,"startTime":"0","endTime":"0","summary":"东阳光将业绩预增归结为三大引擎。最引人注目的是新赛道的突破:智算中心液冷及人形 机器人 领域布局加速, 具身智能 机器人业务已实现营收。Choice数据显示,东阳光实业和宜昌东阳光药业分别质押5.6亿股和5.2亿股,质押率高达90.96%和95.68%。目前,东阳光已与 中际旭创 、智元机器人合作成立子公司,切入当下火热的液冷和机器人赛道。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714171148a6a85a66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714171148a6a85a66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1515","01558"],"gpt_icon":0},{"id":"2551900422","title":"每日卖空追踪 | 东阳光长江药业 07月14日卖空量成交23.2万股,卖空比例为1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551900422","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551900422?lang=zh_cn&edition=full","pubTime":"2025-07-14 16:30","pubTimestamp":1752481821,"startTime":"0","endTime":"0","summary":"东阳光长江药业北京时间07月14日,涨8.76%,卖空量成交23.2万股%,较上一交易日增加26.5%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714172327a4498d66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714172327a4498d66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01558","BK1191","BK1515"],"gpt_icon":0},{"id":"1138375746","title":"港股创新药概念股再度走高!商保创新药目录有望落地","url":"https://stock-news.laohu8.com/highlight/detail?id=1138375746","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1138375746?lang=zh_cn&edition=full","pubTime":"2025-07-14 10:39","pubTimestamp":1752460762,"startTime":"0","endTime":"0","summary":"7月14日,港股创新药概念股再度走高,$博安生物(06955)$涨至20%,$恒瑞医药(01276)$、$丽珠医药(01513)$涨超7%,$东阳光长江药业(01558)$、$四环医药(00460)$涨超5%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"399bd16c74a9d25bcf8925b16d905fdf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","06955","01513","BK4614","01558","600276","YANG","01276","LU2488822045.USD","07226","HSCEI","LU0405327494.USD","BK0188","HSTECH","BK1515","00460","06978","LU1997244956.HKD","LU1997245177.USD","LU0405327148.USD"],"gpt_icon":0},{"id":"2550939452","title":"向全球输出创新,东阳光药有望成为中国创新药新样本","url":"https://stock-news.laohu8.com/highlight/detail?id=2550939452","media":"中国网财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550939452?lang=zh_cn&edition=full","pubTime":"2025-07-11 17:31","pubTimestamp":1752226265,"startTime":"0","endTime":"0","summary":"截至目前,东阳光药拥有:全球150款获批药物;超过100款在研药物;中国市场3款1类创新药上市、1款1类创新药申请上市……同时,东阳光药也是鲜有能够递交美国FDA申请,且有望成为首家可豁免3期临床试验而在美国上市甘精胰岛素类似药的企业。上述业内人士指出,当中国药企普遍面临价格内卷、创新乏力、融资受限、国际化受阻等瓶颈时,老牌药企东阳光药率先实现转型,向全球反向输出创新,有望成为中国创新药新样本。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711173602a44486b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711173602a44486b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01558","BK1515","BK1574","BK1161","06978"],"gpt_icon":0},{"id":"2550455939","title":"每日卖空追踪 | 东阳光长江药业 07月11日卖空量成交6.1万股,卖空比例为0.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550455939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550455939?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:30","pubTimestamp":1752222623,"startTime":"0","endTime":"0","summary":"东阳光长江药业北京时间07月11日,涨1.07%,卖空量成交6.1万股%,较上一交易日减少68.62%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711172322a4447efe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711172322a4447efe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","01558","BK1515"],"gpt_icon":0},{"id":"2550610185","title":"每日卖空追踪 | 东阳光长江药业 07月10日卖空量成交11.1万股,卖空比例为1.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550610185","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550610185?lang=zh_cn&edition=full","pubTime":"2025-07-10 16:30","pubTimestamp":1752136222,"startTime":"0","endTime":"0","summary":"东阳光长江药业北京时间07月10日,涨3.62%,卖空量成交11.1万股%,较上一交易日减少50.71%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710171919a6a1474b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710171919a6a1474b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1191","01558"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hec-changjiang.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0.3428},{"period":"1year","weight":0.823},{"period":"ytd","weight":0.8344}],"compareEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.0058},{"period":"3month","weight":0.0262},{"period":"6month","weight":0.0964},{"period":"1year","weight":0.3336},{"period":"ytd","weight":0.3004}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"宜昌东阳光长江药业股份有限公司是一家主要从事抗感染、内分泌及代谢类疾病等治疗领域产品开发、生产及销售的中国公司。该公司的主要产品包括可威(磷酸奥司他韦胶囊及颗粒)、尔同舒(苯溴马隆片)、欧美宁(替米沙坦片)、琳罗星(盐酸莫西沙星片),以及奥美沙坦酯片等产品。该公司还从事集采业务。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.043062},{"month":2,"riseRate":0.8,"avgChangeRate":0.085594},{"month":3,"riseRate":0.4,"avgChangeRate":-0.060017},{"month":4,"riseRate":0.7,"avgChangeRate":0.045285},{"month":5,"riseRate":0.5,"avgChangeRate":-0.005165},{"month":6,"riseRate":0.7,"avgChangeRate":0.069778},{"month":7,"riseRate":0.5,"avgChangeRate":-0.04333},{"month":8,"riseRate":0.3,"avgChangeRate":-0.027578},{"month":9,"riseRate":0.444444,"avgChangeRate":-0.045757},{"month":10,"riseRate":0.444444,"avgChangeRate":0.024639},{"month":11,"riseRate":0.777778,"avgChangeRate":0.132189},{"month":12,"riseRate":0.555556,"avgChangeRate":0.011021}],"exchange":"SEHK","name":"东阳光长江药业","nameEN":"HEC CJ PHARM"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"东阳光长江药业(01558)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供东阳光长江药业(01558)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"东阳光长江药业,01558,东阳光长江药业股票,东阳光长江药业股票老虎,东阳光长江药业股票老虎国际,东阳光长江药业行情,东阳光长江药业股票行情,东阳光长江药业股价,东阳光长江药业股市,东阳光长江药业股票价格,东阳光长江药业股票交易,东阳光长江药业股票购买,东阳光长江药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"东阳光长江药业(01558)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供东阳光长江药业(01558)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}